Skip to main content
CytoMed Therapeutics Limited (GDTC)
NASDAQ: GDTC · Real-Time Price · USD
2.250
+0.030 (1.35%)
At close: Mar 28, 2025, 4:00 PM
2.182
-0.068 (-3.04%)
After-hours: Mar 28, 2025, 6:00 PM EDT

CytoMed Therapeutics Revenue

CytoMed Therapeutics had revenue of 224.18K SGD in the half year ending June 30, 2024, with 200.74% growth. This brings the company's revenue in the last twelve months to 447.70K, down -21.95% year-over-year. In the year 2023, CytoMed Therapeutics had annual revenue of 507.74K with 39.52% growth.

Revenue (ttm)
447.70K SGD
Revenue Growth
-21.95%
P/S Ratio
78.62
Revenue / Employee
15,989 SGD
Employees
28
Market Cap
25.97M USD

Revenue Chart

* This company reports financials in SGD.

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023507.74K143.82K39.52%
Dec 31, 2022363.91K250.07K219.67%
Dec 31, 2021113.84K54.37K91.43%
Dec 31, 202059.47K--
Dec 31, 2019---
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

GDTC News

More News